
Robert E. Mosser
Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3714, 3715, 3713, 3712 |
| Total Applications | 839 |
| Issued Applications | 347 |
| Pending Applications | 141 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9384600
[patent_doc_number] => 20140088082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS'
[patent_app_type] => utility
[patent_app_number] => 14/094842
[patent_app_country] => US
[patent_app_date] => 2013-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7065
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14094842
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/094842 | Inhibitors of the plasmodial surface anion channel as antimalarials | Dec 2, 2013 | Issued |
Array
(
[id] => 9384667
[patent_doc_number] => 20140088149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'BACTERIAL THIOREDOXIN REDUCTASE INHIBITORS AND METHODS FOR USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/088559
[patent_app_country] => US
[patent_app_date] => 2013-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11588
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14088559
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/088559 | BACTERIAL THIOREDOXIN REDUCTASE INHIBITORS AND METHODS FOR USE THEREOF | Nov 24, 2013 | Abandoned |
Array
(
[id] => 9538386
[patent_doc_number] => 20140163034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'INHIBITORS OF ANANDAMIDE TRANSPORT AND THEIR THERAPEUTIC USES'
[patent_app_type] => utility
[patent_app_number] => 14/089387
[patent_app_country] => US
[patent_app_date] => 2013-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 29188
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14089387
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/089387 | INHIBITORS OF ANANDAMIDE TRANSPORT AND THEIR THERAPEUTIC USES | Nov 24, 2013 | Abandoned |
Array
(
[id] => 12305748
[patent_doc_number] => 09938281
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Purine inhibitors of human phosphatidylinositol 3-kinase delta
[patent_app_type] => utility
[patent_app_number] => 14/443314
[patent_app_country] => US
[patent_app_date] => 2013-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42949
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 332
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443314
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443314 | Purine inhibitors of human phosphatidylinositol 3-kinase delta | Nov 14, 2013 | Issued |
Array
(
[id] => 11100787
[patent_doc_number] => 20160297758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'PYRROLIDINYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/442514
[patent_app_country] => US
[patent_app_date] => 2013-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24034
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442514
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442514 | Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors | Nov 12, 2013 | Issued |
Array
(
[id] => 10398103
[patent_doc_number] => 20150283111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'METHODS OF TREATING PATIENTS INFECTED WITH HIV AND HTLV'
[patent_app_type] => utility
[patent_app_number] => 14/442865
[patent_app_country] => US
[patent_app_date] => 2013-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8989
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442865
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442865 | Methods of treating patients infected with HIV and HTLV | Nov 12, 2013 | Issued |
Array
(
[id] => 11922640
[patent_doc_number] => 09790210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'N-(monocyclic aryl),N\'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/442604
[patent_app_country] => US
[patent_app_date] => 2013-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57599
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442604
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442604 | N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors | Nov 11, 2013 | Issued |
Array
(
[id] => 9721037
[patent_doc_number] => 20140256738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'USE OF SELECTIVE DOPAMINE D4 RECEPTOR AGONISTS FOR TREATING SEXUAL DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 14/076555
[patent_app_country] => US
[patent_app_date] => 2013-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8538
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14076555
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/076555 | USE OF SELECTIVE DOPAMINE D4 RECEPTOR AGONISTS FOR TREATING SEXUAL DYSFUNCTION | Nov 10, 2013 | Abandoned |
Array
(
[id] => 10407036
[patent_doc_number] => 20150292045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'ALTERNATIVE USES FOR HBV ASSEMBLY EFFECTORS'
[patent_app_type] => utility
[patent_app_number] => 14/441621
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10069
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14441621
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/441621 | ALTERNATIVE USES FOR HBV ASSEMBLY EFFECTORS | Nov 7, 2013 | Abandoned |
Array
(
[id] => 9339705
[patent_doc_number] => 20140066487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'ANTIVIRAL COMPOUNDS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/071870
[patent_app_country] => US
[patent_app_date] => 2013-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9020
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14071870
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/071870 | Antiviral compounds and methods | Nov 4, 2013 | Issued |
Array
(
[id] => 11595662
[patent_doc_number] => 09642806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-09
[patent_title] => 'Antifungal compositions with improved bioavailability'
[patent_app_type] => utility
[patent_app_number] => 14/069842
[patent_app_country] => US
[patent_app_date] => 2013-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7183
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14069842
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/069842 | Antifungal compositions with improved bioavailability | Oct 31, 2013 | Issued |
Array
(
[id] => 11595714
[patent_doc_number] => 09642858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-09
[patent_title] => 'Use of resazurin, or analogs thereof, for antibacterial therapy'
[patent_app_type] => utility
[patent_app_number] => 14/439651
[patent_app_country] => US
[patent_app_date] => 2013-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11068
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439651
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/439651 | Use of resazurin, or analogs thereof, for antibacterial therapy | Oct 28, 2013 | Issued |
Array
(
[id] => 9319351
[patent_doc_number] => 20140051689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'Polycyclic Agents for the Treatment of Respiratory Syncytial Virus Infections'
[patent_app_type] => utility
[patent_app_number] => 14/062780
[patent_app_country] => US
[patent_app_date] => 2013-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16976
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14062780
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/062780 | Polycyclic Agents for the Treatment of Respiratory Syncytial Virus Infections | Oct 23, 2013 | Abandoned |
Array
(
[id] => 9450067
[patent_doc_number] => 20140121237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'Methods for Inhibiting Virus Replication'
[patent_app_type] => utility
[patent_app_number] => 14/052998
[patent_app_country] => US
[patent_app_date] => 2013-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20679
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14052998
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/052998 | Methods for Inhibiting Virus Replication | Oct 13, 2013 | Abandoned |
Array
(
[id] => 9293943
[patent_doc_number] => 20140037577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'ANTI-PARASITIC METHODS AND COMPOSITIONS UTILIZING DIINDOLYLMETHANE-RELATED INDOLES'
[patent_app_type] => utility
[patent_app_number] => 14/051248
[patent_app_country] => US
[patent_app_date] => 2013-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20548
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14051248
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/051248 | Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles | Oct 9, 2013 | Issued |
Array
(
[id] => 10339098
[patent_doc_number] => 20150224103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'MEK INHIBITORS IN THE TREATMENT OF VIRUS DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/434328
[patent_app_country] => US
[patent_app_date] => 2013-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11477
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434328
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/434328 | MEK inhibitors in the treatment of virus diseases | Oct 7, 2013 | Issued |
Array
(
[id] => 10353471
[patent_doc_number] => 20150238473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING INFECTION'
[patent_app_type] => utility
[patent_app_number] => 14/431031
[patent_app_country] => US
[patent_app_date] => 2013-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 61505
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431031
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431031 | METHODS AND COMPOSITIONS FOR TREATING INFECTION | Sep 26, 2013 | Abandoned |
Array
(
[id] => 10174938
[patent_doc_number] => 09205125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Compounds for enzyme inhibition'
[patent_app_type] => utility
[patent_app_number] => 14/038591
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23382
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14038591
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/038591 | Compounds for enzyme inhibition | Sep 25, 2013 | Issued |
Array
(
[id] => 10174939
[patent_doc_number] => 09205126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Compounds for enzyme inhibition'
[patent_app_type] => utility
[patent_app_number] => 14/038626
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23383
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14038626
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/038626 | Compounds for enzyme inhibition | Sep 25, 2013 | Issued |
Array
(
[id] => 10174937
[patent_doc_number] => 09205124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Compounds for enzyme inhibition'
[patent_app_type] => utility
[patent_app_number] => 14/038515
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23385
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14038515
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/038515 | Compounds for enzyme inhibition | Sep 25, 2013 | Issued |